Adverum Biotech
Marina Allen has extensive experience in accounting, having worked in various roles such as Associate Director, Accounting Manager, Senior Accountant, and Lab Manager at companies like Adverum Biotechnologies, Coherus BioSciences, and Allscripts. Marina has managed accounting operations, accounts payable, cash management, fixed assets, and other financial functions. Marina has also prepared financial statements, reconciled accounts, and ensured compliance with internal controls. Marina holds a Bachelor of Science in Commerce with a focus on Accounting and Economics from Saint Scholastica's College in Manila.
Adverum Biotech
9 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.